BAUDAX BIO INC (BXRX)
US07160F4046 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 490K | 1.08M 120.41% | 1.27M 17.59% | -100.00% | 33.66M | 93.84M 178.79% | |||
| EBITDA YoY % growth | -72.23M -125.44% | -16.19M 77.59% | -30.8M -90.24% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -74.79M -129.98% | -19.01M 74.58% | -32.97M -73.44% | -21.454M 34.93% | -21.42M 0.16% | -21.93M -2.38% | -2.091M 90.47% | 34.272M 1,739.02% | |
| Operating Margin | -15,263.27% | -1,760.19% | -2,596.06% | N/A | N/A | N/A | -6.21% | 36.52% | |
| EPS YoY % growth | -7,728.00 -47.86% | -578.80 92.51% | -207.53 64.14% | -1.68 99.19% | -0.38 77.58% | -0.33 13.51% | -0.05 84.38% | 0.44 960.00% |
All data in USD
| Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.54 97.95% | -0.12 99.01% | -0.12 96.87% | -0.09 93.96% | -0.09 83.02% | -0.08 33.33% |
| Revenue Q2Q % growth | -100.00% | -100.00% | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.692M 35.64% | -4.794M 22.30% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -1.52 96.38% | -2.08 | 0.56 | 26.95% |
| Q1 2023 Q2Q % growth | -3.91 96.92% | 5.87 | -9.78 | -166.67% |
| Q4 2022 Q2Q % growth | -12.33 -103.07% | -9.96 | -2.37 | -23.85% |
| Q3 2022 Q2Q % growth | -26.40 90.57% | -21.62 | -4.78 | -22.09% |
| Q2 2022 Q2Q % growth | -42.00 86.96% | -51.82 | 9.82 | 18.94% |
| Q1 2022 Q2Q % growth | -126.80 66.46% | -75.48 | -51.32 | -67.99% |
| Q4 2021 Q2Q % growth | 401.20 152.10% | 60.18 | 341.02 | 566.67% |
| Q3 2021 Q2Q % growth | -280.00 -132.26% | -221.34 | -58.66 | -26.50% |
| Q2 2021 Q2Q % growth | -322.00 86.63% | -285.60 | -36.40 | -12.75% |
| Q1 2021 Q2Q % growth | -378.00 93.02% | -276.08 | -101.92 | -36.92% |
| Q4 2020 Q2Q % growth | -770.00 29.49% | -866.32 | 96.32 | 11.12% |
| Q3 2020 Q2Q % growth | 868.00 | -1,051.96 | 1,919.96 | 182.51% |
| Q2 2020 Q2Q % growth | -2,408.00 | -932.96 | -1,475.04 | -158.10% |
| Q1 2020 Q2Q % growth | -5,418.00 | -2,551.36 | -2,866.64 | -112.36% |
| Q4 2019 Q2Q % growth | -1,092.00 | -1,337.56 | 245.56 | 18.36% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | 310K -22.50% | 310K | % | |
| Q3 2022 Q2Q % growth | 240K -14.29% | 984.3K | -744.3K | -75.62% |
| Q2 2022 Q2Q % growth | -100.00% | 788.46K | -788.46K | -100.00% |
| Q1 2022 Q2Q % growth | -100.00% | 568.14K | -568.14K | -100.00% |
| Q4 2021 Q2Q % growth | 400K 400.00% | 637.5K | -237.5K | -37.25% |
| Q3 2021 Q2Q % growth | 280K 300.00% | 612K | -332K | -54.25% |
| Q2 2021 Q2Q % growth | 200K -42.86% | 476.003K | -276.003K | -57.98% |
| Q1 2021 Q2Q % growth | 200K | 645.997K | -445.997K | -69.04% |
| Q4 2020 Q2Q % growth | 80K | 1.666M | -1.586M | -95.20% |
| Q3 2020 Q2Q % growth | 70K | 1.02M | -950K | -93.14% |
| Q2 2020 Q2Q % growth | 350K | 135.997K | 214.003K | 157.36% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 42.39% | 0% | -71.87% |
| Revenue | N/A | N/A | N/A | N/A |